↓ Skip to main content

Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
125 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd004157.pub2
Pubmed ID
Authors

Reto Baldinger, Hans Dieter Katzberg, Markus Weber

Abstract

Cramps are painful, involuntary muscle contractions. They commonly affect people with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) at all stages of the disease. To date, the treatment of muscle cramps in ALS has been largely empirical without any evidence from randomised controlled trials.

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 124 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 18%
Researcher 21 17%
Student > Ph. D. Student 14 11%
Student > Bachelor 13 10%
Student > Postgraduate 9 7%
Other 27 22%
Unknown 18 14%
Readers by discipline Count As %
Medicine and Dentistry 52 42%
Nursing and Health Professions 21 17%
Agricultural and Biological Sciences 7 6%
Psychology 6 5%
Social Sciences 3 2%
Other 17 14%
Unknown 19 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2016.
All research outputs
#4,490,801
of 14,948,564 outputs
Outputs from Cochrane database of systematic reviews
#7,304
of 11,056 outputs
Outputs of similar age
#37,268
of 126,154 outputs
Outputs of similar age from Cochrane database of systematic reviews
#60
of 103 outputs
Altmetric has tracked 14,948,564 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,056 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.6. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.